Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)
Clinical trial NCT07671885 · RECRUITING
Trial details
- NCT number
- NCT07671885
- Sponsor
- Tokyo Women's Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-28
- Primary completion
- 2038-01-27
- Enrollment
- 950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.